Penn Today Online

Related Links
Find a Specialist
Make a Referral Online or call 1-800-789-PENN
Patient Education Articles
 

 


 Penn Today Online

Current Issue
Bloodless Robotic Surgery for Gynecologic Cancers
Good Shepherd Rehabilitation Network & Penn Medicine: Partners in Post-Acute Care
Importance of Evaluation for Obstructive Sleep Apnea in Obese Patients with Type 2 Diabetes
Physician Announcements
Archive of Articles
 
Subscribe to the Newsletter
Newsletter RSS Feed RSS feed
   

Home
Penn Today Online
Referral Directory
Physician Tools
Urgent Patient Transfer
Research
Upcoming CMEs

Clinical Briefing: Continuous Positive Airway Pressure Therapy for Patients with Obstructive Sleep Apnea and Atrial Fibrillation

March/April 2009

The Penn Sleep Centers are currently using continuous positive airway pressure (CPAP) to treat patients with obstructive sleep apnea (OSA) who have atrial fibrillation. The primary therapy for OSA, CPAP has known antihypertensive and antisympathetic effects, and has been demonstrated to reduce the risk of recurrent atrial fibrillation.

Obstructive sleep apnea is characterized by repetitive pharyngeal collapse during sleep resulting in blockage of the airway, hypoxia and sleep disruption. OSA is very common in the US population— recent data suggests that approximately 20 percent of the population is affected. Multiple studies have demonstrated a strong association between atrial fibrillation and OSA. Patients with OSA are more likely to have atrial fibrillation than patients without OSA.

Furthermore, in patients that undergo cardioversion for atrial fibrillation, OSA—if present—has been associated with a high rate of atrial fibrillation recurrence. Emerging data continues to elucidate the pathophysiological relationship between OSA and atrial fibrillation. The hypoxemia and hypercapnea that occur in OSA are known to be arrhythmogenic. Other effects of the disorder, including increased sympathetic drive and elevated C-reactive protein levels, are associated with the pathogenesis of atrial fibrillation.

The Penn Sleep Centers have been using new CPAP technology to improve patient adherence to therapy and allow physicians to track information on patient’s sleeping patterns. In addition to alerting the patient and Sleep Center staff when there is a mask leak, the new technology provides information on whether apnea has been eliminated and whether themachine is being used on a nightly basis.

CASE STUDY
Mr. J, a 49-year-old man presented to the Emergency Department (ED) with palpitations, light-headedness and shortness of breath. He denied chest pain. His symptoms had started 2 hours prior, during the night (at approximately 11pm) and woke him from sleep. His medical history was significant only for paroxysmal atrial fibrillation and hypertension for which the patient was taking HCTZ 25mg once daily.

In the past, he had one episode of atrial fibrillation confirmed by EKG at his primary physician’s office. The episode was self-limited and resolved without specific intervention within 24 hours of onset. At that time, nuclear stress testing was negative for ischemia and echocardiogram revealed left ventricular hypertrophy and mildly elevated pulmonary artery pressure. Thyroid functions were within normal limits.


Figure 1. Macroglossia and tongue ridging in a patient with OSA.

Examination in the ED revealed an obese man, in respiratory distress with blood pressure of 77/45 and a heart rate of 165/minute. EKG confirmed atrial fibrillation with rapid ventricular response; ST segments appeared normal. Cardiac enzymes were within normal limits. Cardioversion with 100J successfully converted the patient to sinus rhythm.

A review of the patient’s history found excessive daytime somnolence and loud snoring. Focused upper airway examination revealed macroglossia, tongue ridging and a crowded oropharynx (Fig. 1). Mr. J had an overnight polysomnogram (Fig. 2) as an outpatient, which confirmed severe obstructive sleep apnea associated with severe oxyhemoglobin desaturation (oxyhemoglobin nadir = 75%). The apnea/hypopnea index equaled 37 events per hour. CPAP therapy was commenced. One year later, the patient continued to be compliant with CPAP therapy. His excessive daytime somnolence had markedly improved, his BMI had decreased after having initiated a regular exercise routine and no further episodes of atrial fibrillation had occurred.


Figure 2. Polysomnogram demonstrating severe oxyhemoglobin desaturation in a patient with OSA.

Our Team of Faculty
Comprised of a consortium of clinicians from the departments of medicine, neurology, psychiatry, otorhinolaryngology and oral and maxillofacial surgery, the Penn Sleep Center is one of only three sleep centers in the United States designated by the National Institutes of Health as a specialized center for research in sleep. This concentration of physicians from different departments permits a comprehensive approach to the diagnosis and treatment of sleep disorders and their comorbidities. With seven locations in the Philadelphia area, the Sleep Center currently performs more than 5,000 sleep studies each year.

Allan I. Pack, MB, ChB, PhD
Chief, Division of Sleep Medicine
Professor of Medicine

Charles R. Cantor, MD, DABSM
Medical Director, Penn Sleep Centers
Clinical Associate Professor of Neurology

Maria Antoniou, MD, DABSM
Assistant Professor of Clinical Medicine

Eliot Friedman, MD
Instructor in Medicine

Philip Gehrman, PhD, CBSM
Assistant Professor of Psychiatry

Nalaka S. Gooneratne, MD, DABSM
Assistant Professor of Medicine

Indira Gurubhagavatula, MD, MPH
Assistant Professor of Medicine

Nirav Patel, MD
Assistant Professor of Clinical Medicine

Grace W. Pien, MD, MSCE, DABSM
Assistant Professor of Medicine

David M. Raizen, MD, PhD, DABSM
Assistant Professor of Neurology

Ilene M. Rosen, MD, MSCE, DABSM
Assistant Professor of Clinical Medicine

Aharon E. Sareli, MD
Assistant Professor of Clinical Medicine

Sharon L. Schutte-Rodin, MD, DABSM
Clinical Associate Professor of Medicine

Richard J. Schwab, MD, DABSM
Professor of Medicine

Sigrid C. Veasey, MD, DABSM
Associate Professor of Medicine

Mark Wu, MD, PhD
Instructor in Neurology

Access
Patient appointments are available at:

Penn Sleep Centers
Hospital of the University of Pennsylvania***†

11th Floor, Gates Building
3400 Spruce Street
Philadelphia, PA 19104

Penn Sleep Center*†
3624 Market Street, Suite 201
Philadelphia, PA 19104

Pennsylvania Hospital*
800 Spruce Street
Philadelphia, PA 19107

Penn Medicine at Radnor**†
250 King of Prussia Road
2nd Floor
Radnor, PA, 19087

Penn Sleep Center at the Sheraton University City Hotel***†
36th & Chestnut Streets
Philadelphia, PA 19104

Penn Sleep Center at the Pavilion at Doyestown Hospital***
599 West State Street, Suite 101
Doylestown, PA 18901

Penn Sleep Center at the Hilton Homewood Suites***†
681 Shannondell Blvd.
Audubon, PA 19403

A facility of the Hospital of the University of Pennsylvania
* Indicates overnight sleep study site and sleep specialist site
** Indicates sleep specialist site
*** Indicates overnight sleep study site

To refer a patient and/or consult with a doctor:

 


Referring Physicians: To speak with a Penn physician or refer a patient, contact PennHealth through the secure online referral form or by calling
1-800-789-PENN (7366).

   
   

 

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2010, The Trustees of the University of Pennsylvania space